CLVT: Divestiture of Life Sciences & Healthcare for $600M boosts focus, margins, and debt reduction
The company is divesting its Life Sciences & Healthcare segment for $600 million to Altaris, sharpening its focus on core segments and improving its financial profile. The deal is expected to close by year-end, with proceeds used to reduce debt and enhance recurring revenue mix.Based on Clarivate P…